Literature DB >> 9414456

Angiogenesis in the ovary.

D A Redmer1, L P Reynolds.   

Abstract

In adult tissues, capillary growth (angiogenesis) occurs normally during tissue repair, such as in the healing of wounds and fractures. Inappropriate capillary growth is associated with various pathological conditions, including tumour growth, retinopathies, haemangiomas, fibroses and rheumatoid arthritis in the case of rampant capillary growth, and nonhealing wounds and fractures in the case of inadequate capillary growth. The female reproductive organs exhibit marked, periodic growth and regression, accompanied by equally striking changes in their rates of blood flow. It is not surprising, therefore, that they are some of the few adult tissues in which angiogenesis occurs as a normal process. Ovarian follicles and corpora lutea have been shown to contain and produce angiogenic factors. These angiogenic factors appear to be heparin-binding and to belong to the fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) families of proteins. In addition, factors regulating gap junctional communication may play a critical role in coordinating the interactions between luteal vascular and nonvascular tissues. Further elucidation of the specific physiological roles of these factors in follicular and luteal growth, development and function will ultimately lead to improved methods for regulating fertility in mammals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9414456     DOI: 10.1530/ror.0.0010182

Source DB:  PubMed          Journal:  Rev Reprod        ISSN: 1359-6004


  45 in total

Review 1.  Angiogenesis in the corpus luteum.

Authors:  L P Reynolds; A T Grazul-Bilska; D A Redmer
Journal:  Endocrine       Date:  2000-02       Impact factor: 3.633

Review 2.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

3.  Injection of antiangiogenic agents into the macaque preovulatory follicle: disruption of corpus luteum development and function.

Authors:  Timothy M Hazzard; Richard M Rohan; Theodore A Molskness; John W Fanton; Robert J D'Amato; Richard L Stouffer
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

Review 4.  Ovarian aging and premature ovarian failure.

Authors:  Yavuz Emre Sükür; Içten Balık Kıvançlı; Batuhan Ozmen
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

5.  Cooperative effects of 17β-estradiol and oocyte-derived paracrine factors on the transcriptome of mouse cumulus cells.

Authors:  Chihiro Emori; Karen Wigglesworth; Wataru Fujii; Kunihiko Naito; John J Eppig; Koji Sugiura
Journal:  Endocrinology       Date:  2013-09-13       Impact factor: 4.736

6.  Rapid changes in ovarian mRNA induced by brief photostimulation in Siberian hamsters (Phodopus sungorus).

Authors:  Asha Shahed; Carling F McMichael; Kelly A Young
Journal:  J Exp Zool A Ecol Genet Physiol       Date:  2015-07-14

7.  Mathematical analysis of a model for the growth of the bovine corpus luteum.

Authors:  Sotiris A Prokopiou; Helen M Byrne; Mike R Jeffrey; Robert S Robinson; George E Mann; Markus R Owen
Journal:  J Math Biol       Date:  2013-12-13       Impact factor: 2.259

8.  Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice.

Authors:  Ariella Shikanov; Zheng Zhang; Min Xu; Rachel M Smith; Aniruddha Rajan; Teresa K Woodruff; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2011-09-21       Impact factor: 3.845

9.  Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study.

Authors:  Jing Xie; Kathryn L Terry; Elizabeth M Poole; Kathryn M Wilson; Bernard A Rosner; Walter C Willett; Hubert W Vesper; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-02-15       Impact factor: 4.254

10.  The regulators of VEGF expression in mouse ovaries.

Authors:  So Young Shin; Ho-Jung Lee; Duck-Sung Ko; Hoi-Chang Lee; Won Il Park
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.